Clinical and evolutionary aspects in pregnant women with probable Oropouche fever from semi-urban communities
Abstract
Introduction: The beginning of 2026 unfolds within a complex and dynamic epidemiological scenario, where the threat of arboviral diseases is being rapidly redefined.
Objective: To characterize the population of pregnant women with probable Oropouche fever belonging to semi-urban communities in Santiago de Cuba province, according to selected clinical and evolutionary variables.
Methods: A descriptive observational study of the case series type was conducted in pregnant women attended and followed up in the community, between the months of May 2024 and May 2025.
Results: Fever and headache predominated in the series (93.3% and 92.0%, respectively). The gastroenteric clinical form marked important differences in its presentation (64.0%). Dehydration (69.3%) and electrolyte disturbances (61.3%) were frequent clinical complications. On the other hand, among obstetric complications, threatened abortion (12.0%) and completed abortion (4.0%) marked the difference. Others, such as fetal demise and induced abortion, were also of interest.
Conclusions: The clinical and evolutionary presentations of pregnant women with probable Oropouche fever virus infection manifest variably, although non-severe presentations mark the difference. There are digestive and obstetric complications with some differences from what is reported in the specialized literature.
Downloads
References
1.Cuba. Centro Nacional de Información de Ciencias Médicas. Biblioteca Médica Nacional. Vigilancia integrada de arbovirosis: Dengue, Chikungunya, Oropouche y Zika en un escenario de cambio climático. Bibliomed. 2026 [citado 09/05/2025];33(1):[aprox. 12 p.]. Disponible en: https://temas.sld.cu/oropouche/2026/03/26/vigilancia-integrada-de-arbovirosis-dengue-chikungunya-oropouche-y-zika-en-un-escenario-de-cambio-climatico/
2.Reyes Tápanes MC, Rodríguez Sánchez L, Díaz Ojeda JL, Torres Cancino I. Arbovirosis emergentes y reemergentes: un enfoque desde la atención primaria de salud. Revista Progaleno. 2021 [citado 05/01/2026];4(3):222-37. Disponible en: https://revprogaleno.sld.cu/index.php/progaleno/article/view/220/215
3.Organización Panamericana de la Salud. Washington, DC: OPS; c2026. [actualizado 13/08/2025; citado 09/05/2025]. Actualización Epidemiológica Oropouche en la Región de las Américas; [aprox. 1p.]. Disponible en: https://www.paho.org/es/documentos/actualizacion-epidemiologica-oropouche-region-americas-13-agosto-2025
4.Schwartz DA, Dashraath P, Baud D. Oropouche Virus (OROV) in Pregnancy: An Emerging Cause of Placental and Fetal Infection Associated with Stillbirth and Microcephaly following Vertical Transmission. Viruses. 2024 [citado 06/06/2026];16(9):1435. Disponible en: https://www.mdpi.com/1999-4915/16/9/1435
5.CDC. Estados Unidos: Public Health Publications; [actualizado 19/11/025; citado 09/05/2025]. Clinical Overview of Oropouche Virus Disease; [aprox. 12p.]. Disponible en: https://www.cdc.gov/oropouche/hcp/clinical-overview/index.html
6.Martínez Cantillo L, Calderín Guillot T, Serra Trapero N, Besse Díaz R. Factores predictivos de gravedad en gestantes con sospecha de fiebre oropouche pertenecientes a comunidades santiagueras. Medisan. Revista médica Santiago. 2026 [citado 09/05/2026];30:e5569. Disponible en: https://medisan.sld.cu/index.php/san/article/view/5569/3961
7.Romero Guzmán I, Amador Ahumada C, Padilla Choperena C, Benítez Cheij L. Riesgos maternos, reproductivos y perinatales de las enfermedades tropicales: Dengue. Rev Avances en Salud. 2020[citado 24/7/2024];(4)1:41-9. Disponible en: https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://revistas.unicordoba.edu.co/index.php/avancesalud/article/download/1747/2516&ved=2ahUKEwiftY6Nz5GXAxUuQzABHRcnJN4QFnoECCEQAQ&usg=AOvVaw3Qc7dlSp_hK2jVDATZVxuX
8.Camacho Moll ME, De León MB, Muñoz Medina JE, Gonzales Salazar F, Tovar Cisneros B, Salinas Martínez AM, et al. Factores asociados con la infección y la hospitalización de casos de Zika durante el brote de 2016-2018 en México. Sci Rep 2025 [citado 16/2/2026];15:37585. Disponible en: https://www.nature.com/articles/s41598-025-16239-3
9.Andreolla AP, Borges AA, Nagashima S, Vaz de Paula CB, de Noronha L, Zanchin NIT, et al. Development of monoclonal antibodies against oropouche virus and its applicability to immunohistochemical diagnosis. Virol J. 2024 [citado 16/2/2026];21(1):81. Disponible en: https://www.researchgate.net/publication/379667222_Development_of_monoclonal_antibodies_against_oropouche_virus_and_its_applicability_to_immunohistochemical_diagnosis
10.Oropouche fever, the mysterious threat [editorial]. Lancet Infect. Dis. 2024 [citado 16/2/2026];24(9):935. Disponible en: https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(24)00516-4.pdf
11.Meteored. Murcia, España: Meteored; c2026[actualizado 23/07/2024; citado 09/05/2025]. La propagación de un virus en América Latina puede causar defectos congénitos; [aprox. 6p.]. Disponible en: https://www.meteored.cl/noticias/ciencia/la-propagacion-de-un-nuevo-virus-en-america-latina-podria-causar-defectos-congenitos.html
12.Gutiérrez De la Cruz Y, Jaqueman Dussac Y, Domínguez Mateos A, Valdés García LE. Características clínico epidemiológicas de casos confirmados de Fiebre de Oropouche en la provincia Santiago de Cuba. Medisan. 2026 [citado 27/12/2026];30:e5464. Disponible en: https://medisan.sld.cu/index.php/san/article/view/5464/3921
13.Cuba. Centro Nacional de Información de Ciencias Médicas. Biblioteca Médica Nacional. Triple epidemia arboviral en Cuba: análisis comparativo y estratégico para la toma de decisiones frente a Dengue, Chikunguña y Oropouche. Factográfico salud. 2025 [citado 09/12/2025];11(11):[aprox. 20p.]. Disponible en: http://files.sld.cu/bmn/files/2025/07/factografico-de-salud julio-2025.pdf
14.Organización Mundial de la Salud. Ginebra, Suiza: OMS; c2026 [actualizado 22/10/2024; citado 06/02/2025]. Enfermedad por Virus Oropouche; [aprox 5.p.]. Disponible en: https://ww w.paho.org/es/temas/enfermedad-por-virus-oropouche
15.Schwarz MM, Price DA, Ganaie SS, Feng A, Mishra N, Hoehl RM, et al. Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1. Proc Natl Acad Sci USA. 2022 [citado 24/07/2024];119(33):e2204706119. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9388146/
16.Cola JP, Dos Santos APB, Zanotti RL, Dela Costa AEDS, Del Carro KB, Coelho LAL, Miranda AE, Vicente CR. Maternal and Fetal Implications of Oropouche Fever, Espírito Santo State, Brazil, 2024. Emerg Infect Dis. 2025 [citado 31/05/2026];31(4):645-51. Disponible en: https://www.researchgate.net/publication/389284525_Maternal_and_Fetal_Implications_of_Oropouche_Fever_Espirito_Santo_State_Brazil_2024
17.Saivish MV, Menezes GL, da Silva RA, de Assis LR, Teixeira IDS, Fulco UL, et al. Acridones as promising drug candidates against Oropouche virus. Curr Res Microb Sci. 2024 [citado 24/07/2024];(6):100217. Disponible en: https://www.sciencedirect.com/science/article/pii/S266651742300038X
18.Vera Mendoza EM. Neuroinvasión por el virus del Oropouche y tormenta inmunológica: una revisión narrativa. Acta Méd Centro. 2025[citado 09/09/ 2026];20:e2352. Disponible en: https://revactamedicacentro.sld.cu/index.php/amc/article/view/2352/1897
19.Rojo Pérez MÁ, Ramírez García EA, Llenas García J. Clinical and Epidemiological Characteristics of an Oropouche Virus Outbreak in Loreto, Peru (October 2024-March 2025). Pathogens. 2026 [citado 24/07/2024];15(1):119. Disponible en: https://www.mdpi.com/2076-0817/15/1/119
20.Srivastava S, Sharma D, Kumar S, Mali SN, Mehta R, Apostolopoulos V, et al. Pregnancy Loss, Oropouche Virus and the Lessons from Pernambuco, Brazil. Infez Med. 2024 [citado 06/06/2026];32(4):417-20. Disponible en: https://www.infezmed.it/media/journal/Vol_32_4_2024_1.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Reinier Besse Diaz, Nancy Serra Trapero , Lázaro Ibrahim Romero García , Tahimí Calderín Guillot , Suniel Johnson Valenciano
This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
